{
    "eid": "2-s2.0-85072761516",
    "title": "Long-term Apomorphine Infusion Users Versus Short-term Users: An International Dual-center Analysis of the Reasons for Discontinuing Therapy",
    "cover-date": "2019-09-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Neurology (clinical)",
            "@code": "2728",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "apomorphine infusion",
        "Parkinson's disease/parkinsonism",
        "retention in treatment"
    ],
    "authors": [
        "Roongroj Bhidayasiri",
        "Onanong Phokaewvarangkul",
        "Kamolwan Boonpang",
        "Thanatat Boonmongkol",
        "Yuwadee Thongchuem",
        "Nitinan Kantachadvanich",
        "Pedro J. Garc\u00eda Ruiz"
    ],
    "citedby-count": 10,
    "ref-count": 44,
    "ref-list": [
        "Impact of the motor complications of Parkinson's disease on the quality of life",
        "Nonmotor symptoms and health-related quality of life in early Parkinson's disease",
        "Quality of life in Parkinson's disease: The relative importance of the symptoms",
        "Continuous dopaminergic stimulation for Parkinson's disease: Facts and fancy",
        "Continuous dopamine-receptor stimulation in advanced Parkinson's disease",
        "Motor and nonmotor complications in Parkinson's disease: An argument for continuous drug delivery?",
        "Apomorphine - Pharmacological properties and clinical trials in Parkinson's disease",
        "Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease - Clinical practice recommendations",
        "A randomized trial of deep-brain stimulation for Parkinson's disease",
        "Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: A randomised, controlled, double-blind, double-dummy study",
        "Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program",
        "Apomorphine and levodopa infusion therapies for advanced Parkinson's disease: Selection criteria and patient management",
        "Pros and cons of apomorphine and l -dopa continuous infusion in advanced Parkinson's disease",
        "Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: An evidence-based review",
        "EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease",
        "Effective delivery of apomorphine in the management of Parkinson disease: Practical considerations for clinicians and Parkinson nurses",
        "Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): A multicentre, double-blind, randomised, placebo-controlled trial",
        "Apomorphine hydrochloride for the treatment of Parkinson's disease",
        "Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: Long-term follow-up study of 64 patients",
        "Motor and non-motor outcomes of continuous apomorphine infusion in 125 Parkinson's disease patients",
        "Continuous subcutaneous apomorphine infusion in Parkinson's disease patients with cognitive dysfunction: A retrospective long-term follow-up study",
        "Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study",
        "Subcutaneous apomorphine in late stage Parkinson's disease: A long term follow up",
        "Continuous subcutaneous apomorphine infusion in advanced Parkinson's disease: 10-year experience with 230 patients",
        "Effects of long-term, continuous subcutaneous apomorphine infusions on motor complications in advanced Parkinson's disease",
        "A 10 year retrospective audit of long-term apomorphine use in Parkinson's disease",
        "Apomorphine: An underutilized therapy for Parkinson's disease",
        "Long-term adherence to apomorphine infusion in patients with Parkinson disease: A 10-year observational study",
        "Understanding the role of the Parkinson's disease nurse specialist in the delivery of apomorphine therpy",
        "Knowledge, attitudes and perceptions of Parkinson's disease: A cross-sectional survey of Asian patients",
        "Comparison of patient rated treatment response with measured improvement in Parkinson's disease",
        "Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy?",
        "Discontinuation of cholinesterase inhibitor treatment and determinants thereof in the Netherlands: A retrospective cohort study",
        "Discontinuation of ropinirole and pramipexole in patients with Parkinson's disease: Clinical practice versus clinical trials",
        "Impact of disease duration in effectiveness of treatment with levodopa-carbidopa intestinal gel and factors leading to discontinuation",
        "Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease",
        "Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up",
        "Long-term response to continuous duodenal infusion of levodopa/carbidopa gel in patients with advanced Parkinson disease: The Barcelona registry",
        "Causes of withdrawal of duodenal levodopa infusion in advanced Parkinson disease",
        "Quantitative demonstration of the efficacy of night-time apomorphine infusion to treat nocturnal hypokinesia in Parkinson's disease using wearable sensors",
        "Sensor-based evaluation and treatment of nocturnal hypokinesia in Parkinson's disease: An evidence-based review",
        "Getting a good night sleep? the importance of recognizing and treating nocturnal hypokinesia in Parkinson's disease",
        "Time for a strategy in night-time dopaminergic therapy? An objective sensor-based analysis of nocturnal hypokinesia and sleeping positions in Parkinson's disease"
    ],
    "affiliation": [
        {
            "affiliation-city": "Madrid",
            "@id": "60026796",
            "affilname": "Universidad Aut\u00f3noma de Madrid",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026796",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Britannia Pharmaceuticals Ltd.",
        "Chula Research Scholar",
        "Chulalongkorn Academic Advancement Fund into Its 2nd Century Project of Chulalongkorn University",
        "Grant for International Research Integration",
        "International Research Network",
        "Medtronics, Novartis",
        "Rachadapiseksomphot Endowment Fund",
        "Teva-Lundbeck",
        "Thailand Research Fund, Chulalongkorn",
        "The Neurological Society of Thailand",
        "Abbott",
        "GlaxoSmithKline",
        "Novartis",
        "Roche",
        "Newton Fund",
        "Chulalongkorn University",
        "National Science and Technology Development Agency",
        "Thailand Research Fund",
        "Ipsen Pharmaceuticals"
    ]
}